ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $356,035,825 | +9.8% | 3,802,177 | +4.7% | 2.42% | +17.8% |
| Q2 2023 | $324,130,268 | -3.9% | 3,631,712 | +15.4% | 2.06% | -13.6% |
| Q1 2023 | $337,327,617 | -12.5% | 3,146,126 | -0.4% | 2.38% | -19.9% |
| Q4 2022 | $385,707,058 | +28.3% | 3,158,168 | +8.5% | 2.98% | +24.6% |
| Q3 2022 | $300,561,000 | +16.0% | 2,910,724 | +4.4% | 2.39% | +17.0% |
| Q2 2022 | $259,201,000 | -16.2% | 2,788,309 | +5.8% | 2.04% | +3.0% |
| Q1 2022 | $309,247,000 | -13.0% | 2,635,027 | -0.2% | 1.98% | -6.2% |
| Q4 2021 | $355,285,000 | +5.6% | 2,640,934 | +25.1% | 2.11% | +4.0% |
| Q3 2021 | $336,551,000 | +26.9% | 2,111,493 | +4.7% | 2.03% | +27.8% |
| Q2 2021 | $265,195,000 | +10.2% | 2,015,927 | +7.9% | 1.59% | +6.1% |
| Q1 2021 | $240,708,000 | -16.6% | 1,867,693 | +8.0% | 1.50% | -12.6% |
| Q4 2020 | $288,510,000 | +4.5% | 1,729,881 | -3.3% | 1.71% | -4.3% |
| Q3 2020 | $276,198,000 | +29.8% | 1,789,774 | +24.4% | 1.79% | +22.2% |
| Q2 2020 | $212,779,000 | +38.6% | 1,438,665 | +5.5% | 1.46% | +8.2% |
| Q1 2020 | $153,526,000 | -12.5% | 1,363,342 | +8.1% | 1.35% | +8.2% |
| Q4 2019 | $175,396,000 | +62.0% | 1,260,756 | +12.2% | 1.25% | +44.1% |
| Q3 2019 | $108,269,000 | -3.2% | 1,124,054 | +15.7% | 0.87% | +3.0% |
| Q2 2019 | $111,897,000 | +38.5% | 971,752 | +41.5% | 0.84% | +36.9% |
| Q1 2019 | $80,806,000 | +139.2% | 686,545 | +27.3% | 0.62% | +113.5% |
| Q4 2018 | $33,776,000 | -18.1% | 539,120 | -7.3% | 0.29% | -0.3% |
| Q3 2018 | $41,222,000 | +46.0% | 581,734 | +37.0% | 0.29% | +37.0% |
| Q2 2018 | $28,243,000 | – | 424,575 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |